Aggressive calorie restriction on top of semaglutide-induced appetite suppression can crash your energy
The World Anti-Doping Agency (WADA), which regulates the drugs and other substances that elite athletes are allowed to take in and out of competition, banned the peptide in 2022 because BPC-157, according to its website, lacks current approval by any governmental regulatory health authority for human therapeutic use. But despite that regulatory action, trainers admit that they still work with elite and pro athletes who choose to take the peptide during downtime to speed recovery from injuries and surgerieswith relatively little fear of repercussions
All GLP-1 agonists carry a precautionary label about thyroid C-cell tumors based on rodent studies, though this has not been confirmed in humans
In contrast, clinical studies show that people taking semaglutide 2.4 mg once weekly (available as Wegovy, but similar to a 2 mg weekly dose of Ozempic) experienced an average weight loss of 15% over 68 weeks
The result is lower peak hormone concentrations and reduced overall hormonal exposure
